---
schema_version: "secwatch.filing_event.v1"
accession: "0001006837-26-000090"
form_type: "8-K"
ticker: "VATE"
cik: "0001006837"
company_name: "INNOVATE Corp."
filed_at: "2026-08-18T12:12:19+00:00"
generated_at: "2026-08-18T12:15:08.266775+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# INNOVATE's MediBeacon TGFR System nominated for 2026 Prix Galien USA Best Medical Technology

## Summary
- MediBeacon TGFR System nominated for 2026 Prix Galien USA Best Medical Technology by The Galien Foundation.
- Winners announced Oct 29, 2026 at American Museum of Natural History in New York City.
- TGFR System is first-in-kind point-of-care kidney function assessment using Lumitrace injection, monitor, and reusable sensor.
- Earlier in 2026, JASN recognized a transdermal GFR assessment article as one of five Editor's Choice articles of 2025.
- MediBeacon is an equity method investment of INNOVATE (NYSE: VATE).

## SEC filing metadata
- accession: 0001006837-26-000090
- form_type: 8-K
- ticker: VATE
- cik: 0001006837
- company_name: INNOVATE Corp.
- filed_at: 2026-08-18T12:12:19+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006837/000100683726000090/0001006837-26-000090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006837/000100683726000090/hchc-20260818.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001006837-26-000090
- JSON: https://secwatch.observer/filing/0001006837-26-000090.json
- Plain text: https://secwatch.observer/filing/0001006837-26-000090.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.